Letter to the Editor

 

Authors

  • Paolo A. Ascierto Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Napoli, Italy

DOI:

https://doi.org/10.19156/cbn.2017.0040

Abstract

No abstract available

Downloads

Published

2017-04-15

How to Cite

1.
Ascierto PA. Letter to the Editor:  . CBN [Internet]. 2017 Apr. 15 [cited 2024 Nov. 22];5(1):43-4. Available from: https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/176

Issue

Vol. 5 No. 1 (2017): April 2017

Section

Letter to the Editor

License

Articles published in Cancer Breaking News are distributed under the CC Attribution-NonCommercial-NoDerivatives 4.0 license, which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon.